MV140 Vaccine Helped People Remain UTI-Free For Years

New Delhi: Urinary Tract Infection (UTI) is a common bacterial infection said to be experienced by half of all women and one in five men. However, a study has shown that more than 50 per cent of people remained UTI-free for up to nine years who received the oral spray-based vaccine ‘MV140’.

According to the study published in the journal European Association of Urology, the MV140 vaccine is a potential alternative to antibiotic treatments. About 54 per cent of study participants remained UTI-free for nine years after the vaccine, with no notable side effects reported.

“Recurrent infections, needing short-term antibiotic treatment, develop in between 20 to 30 per cent of cases,” the study mentioned. This study, conducted by specialists at the UK’s Royal Berkshire Hospital, examined the safety and efficacy of the MV140 vaccine in 89 patients.

“Nine years after first receiving this new UTI vaccine, around half of participants remained infection-free. Overall, this vaccine is safe in the long term and our participants reported having fewer UTIs that were less severe,” said Dr Bob Yang, Consultant Urologist at the Royal Berkshire NHS Foundation Trust, who co-led the study.

MV140 vaccine was administered with two sprays of a pineapple-flavoured suspension under the tongue every day for three months in patients.

Developed by the Spain-based pharmaceutical company Immunotek, MV140 contains four bacterial species in a suspension with water. It is available off-license in 26 countries. In the research, 48 participants remained entirely infection-free during the nine-year follow-up.

The average infection-free period across the cohort was 54.7 months (four and a half years) – 56.7 months for women and 44.3 months, one year less, for men. 40 per cent of participants reported having repeat doses of the vaccine after one or two years, the study noted.

“This follow-up study reveals encouraging data about the long-term safety and effectiveness of the MV140 vaccine,” said Gernot Bonkat, Professor at the Alta Uro Medical Centre for Urology in Switzerland.

Related Posts

  • Pharma
  • May 11, 2024
  • 110 views
ICMR Urges People To Avoid Protein Supplements

New Delhi, 11 May 2024: The Indian Council of Medical Research has pressed for avoiding protein supplements for building body mass and has recommended restricting salt intake, minimising sugar and ultra-processed…

  • Pharma
  • May 11, 2024
  • 81 views
Gujarat FDCA Revokes Licenses Of Two Entities Amidst Rigorous Inspection Campaign

Mumbai: In a bid to uphold stringent regulatory standards and ensure public safety, the Gujarat Food and Drug Control Administration (FDCA) has recently embarked on a series of risk-based inspections targeting…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

ICMR Urges People To Avoid Protein Supplements

ICMR Urges People To Avoid Protein Supplements

Gujarat FDCA Revokes Licenses Of Two Entities Amidst Rigorous Inspection Campaign

Gujarat FDCA Revokes Licenses Of Two Entities Amidst Rigorous Inspection Campaign

Panipat: Wrestler And Buyer Selling Banned Drug Injections Arrested, 3500 Injections Recovered

Panipat: Wrestler And Buyer Selling Banned Drug Injections Arrested, 3500 Injections Recovered

Disclosed all rare to very rare side-effects of Covid vaccine ‘Covishield’ since ’21

Disclosed all rare to very rare side-effects of Covid vaccine ‘Covishield’ since ’21

ICMR Releases Application Form For Testing Of Vector Control Products

ICMR Releases Application Form For Testing Of Vector Control Products

Hyderabad: Youth Selling Tydol Drug Illegally Held By DCA

Hyderabad: Youth Selling Tydol Drug Illegally Held By DCA